Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 186.64

-2.0%

Feb 9 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Andrew H who wrote (7347)	9/23/1997 9:15:00 PM
From: squetch	of 32384

>>Perhaps some of these costs were previously classified under coronary disease?<< I read the study as measuring excess cost compared to nondiabetics. For example both non and diabetics would suffer coronary conditions. The study appeared to measure "how much more" for diabetics. >>Diabetic patients, who represent 3.6% of all members in this HMO, accounted for 11.9% of total health care delivery costs during 1994. These findings are similar to U.S. health care expenditures for diabetes reported by Rubin et al. (2) from the National Medical Expenditures Survey in 1992. << I hope the combo really will help these people. squetch.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next